Investment Case
Delivering sustainable growth through vertical integration, strategic acquisitions, and innovation.

CSG is a leading European defence group, recognised as the second largest producer of medium- and large-calibre ammunition in Europe and the largest global producer of small-calibre ammunition by sales. The Group has rapidly expanded its scale and capabilities through significant organic growth and strategic acquisitions, establishing itself as a diversified manufacturer with a strong international presence.
CSG benefits from strong revenue visibility, supported by a substantial order backlog and long-term contracts with government and institutional customers. The Group’s position as a critical supplier to NATO and allied governments is reinforced by multi-year agreements, providing robust forward earnings certainty.
The Group is highly vertically integrated, controlling key stages of its supply chain for both ammunition and defence systems. In-house production of critical components and strategic investments in raw materials and manufacturing ensure supply security, operational efficiency, and margin enhancement.
CSG operates a diversified business model across defence systems, ammunition, and related technologies, serving both government and civil markets. This balanced portfolio reduces risk and provides resilience, enabling the Group to capture opportunities across multiple sectors and geographies.
The Group demonstrates strong financial performance, with consistent growth in revenues, profitability, and cash generation. Operational excellence, disciplined capital allocation, and a prudent approach to leverage underpin CSG’s financial stability and support ongoing investment.
CSG has an extensive global footprint, supplying products to customers in over 70 countries and maintaining manufacturing sites across Europe and North America. Its broad customer base, including NATO and allied governments, underpins strong export potential and positions the Group to benefit from rising global defence spending.
Modernizing production to reduce carbon footprint and ensuring responsible corporate governance in the defence sector.
Entering new geographic markets (US, Western Europe) and strengthening our position in the global supply chain.
Investing in advanced technologies, digitalisation of production, and AI-driven defense systems.
Czechoslovak Group (CSG) and its subsidiaries do not design, develop, manufacture, distribute, or provide any financial or other support for controversial weapons, as defined under Annex I, Table I, Indicator #14 of Commission Delegated Regulation (EU) 2022/1288 supplementing Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial sector. This includes, but is not limited to:
Anti-personnel mines (Ottawa Treaty),
Cluster munitions (Oslo Convention),
Chemical weapons (Chemical Weapons Convention),
Biological weapons (Biological Weapons Convention),
Weapons containing depleted uranium,
Weapons containing white phosphorus.
In addition, CSG is not involved in any aspect of nuclear weapons manufacturing, whether directly or through its subsidiaries or joint ventures.
CSG does not engage in any activities related to these weapons, nor does it intend to do so in the future. As a result, CSG does not have any exposure to Principal Adverse Impact (PAI) Indicator #14 under the Sustainable Finance Disclosure Regulation (SFDR). This statement is provided to support the information needs of financial market participants subject to Regulation (EU) 2019/2088.
The information contained on this website does not constitute an offer of securities for sale to U.S. persons (as defined in Regulation S under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act") or in the United States, Australia, Canada, Japan or any other jurisdiction where to do so would be unlawful. No securities have been, or will be, registered under the U.S. Securities Act, or with any securities regulatory authority of any state or other jurisdiction in the United States. No securities may be offered or sold, directly or indirectly, into the United States or to, or for the account or benefit of, any U.S. person, absent registration, except in accordance with Rule 144A under the U.S. Securities Act to persons reasonably believed to be Qualified Institutional Buyers ("QIBs") within the meaning of Rule 144A who represent that they are QIBs under Rule 144A.
Whilst CZECHOSLOVAK GROUP a.s. has taken reasonable care to ensure that the information on this website (other than information accessed by hypertext link) is accurate at the time of last revision of the website, CZECHOSLOVAK GROUP a.s. accepts no liability for the accuracy or completeness or use of, nor any liability to update, the information contained on this website. It should not be construed as the giving of advice or the making of a recommendation and should not be relied on as the basis for any decision or action. In particular, actual results and developments may be materially different from any forecast, opinion or expectation expressed on this website.
Certain information on this website is of a historical nature and may now be out of date. All historical information should be understood as speaking from the date of its first publication.
Nothing on this website constitutes an invitation or offer to invest or
deal in the securities of CZECHOSLOVAK GROUP a.s. This website contains certain hypertext links to other websites. CZECHOSLOVAK GROUP a.s. has not reviewed, is not responsible for, and accepts no liability in respect of, any information or opinion contained on any such other website.